JetBlue’s ‘Flight Disruptions’ Refund Policy
Clear policy or moving target?
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
LifeLock’s Identity Theft Protection
Is your Social Security number as vulnerable as this company claims?
The McRib
Lawsuit alleges the McRib is a McScam.
2026 Deceptive Ad Trends
A closer look at what we’ll be monitoring in the new year.
Why ‘Click-to-Cancel’ Still Matters – and Why the FTC Should Try Again
The problem hasn’t gone away.